Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cavaliere

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic CancerValeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control StudyMaria Albanese, Giulia Marrone, Agostino Paolino, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 29, 2020
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunitiesClaudio Luchini, Gaetano Paolino, Paola Mattiolo, et al.
Critical Reviews in Oncology/Hematology|December 19, 2021
Evolving pancreatic cancer treatment: From diagnosis to healthcare managementMichele Milella, Claudio Bassi, Ugo Boggi, et al.
Therapeutic Advances in Medical Oncology|July 21, 2020
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trialValeria Merz, Camilla Zecchetto, Francesca Simionato, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 26, 2021
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patientsDavide Melisi, Alessandro Cavaliere, Stefano Gobbo, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genesAnna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Genome Medicine|October 10, 2024
DNA demethylation triggers cell free DNA release in colorectal cancer cellsValeria Pessei, Marco Macagno, Elisa Mariella, et al.
Journal of Prenatal Medicine|March 23, 2012
Prenatal screening of Cystic Fibrosis: a single centre experienceDomenico Bizzoco, Alvaro Mesoraca, Antonella Cima, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for <i>MGMT</i> Gene Promoter Hypermethylation DetectionMarco Macagno, Valeria Pessei, Noemi Congiusta, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic CancerValeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control StudyMaria Albanese, Giulia Marrone, Agostino Paolino, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 29, 2020
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunitiesClaudio Luchini, Gaetano Paolino, Paola Mattiolo, et al.
Critical Reviews in Oncology/Hematology|December 19, 2021
Evolving pancreatic cancer treatment: From diagnosis to healthcare managementMichele Milella, Claudio Bassi, Ugo Boggi, et al.
Therapeutic Advances in Medical Oncology|July 21, 2020
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trialValeria Merz, Camilla Zecchetto, Francesca Simionato, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 26, 2021
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patientsDavide Melisi, Alessandro Cavaliere, Stefano Gobbo, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genesAnna Maria Militello, Giulia Orsi, Alessandro Cavaliere, et al.
Genome Medicine|October 10, 2024
DNA demethylation triggers cell free DNA release in colorectal cancer cellsValeria Pessei, Marco Macagno, Elisa Mariella, et al.
Journal of Prenatal Medicine|March 23, 2012
Prenatal screening of Cystic Fibrosis: a single centre experienceDomenico Bizzoco, Alvaro Mesoraca, Antonella Cima, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for <i>MGMT</i> Gene Promoter Hypermethylation DetectionMarco Macagno, Valeria Pessei, Noemi Congiusta, et al.
Pageof 4